ENTITY
Medtronic Plc

Medtronic Plc (MDT US)

238
Analysis
Health CareUnited States
Medtronic, PLC develops therapeutic and diagnostic medical products. The Company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic's products are sold worldwide.
more
Refresh
bullishMedtronic Plc
02 Jun 2024 22:00

Medtronic plc: Expansion Of Global Operations & Supply Chain Transformation! - Major Drivers

In its fiscal year 2024 Q4 earnings, Medtronic reported significant revenue growth and strong earnings, demonstrating the effectiveness of its...

Logo
198 Views
Share
19 Jun 2024 02:21

Brain Science - An Opportunity or a Trap?

We identify four key areas of investment opportunities in brain science, including neurotherapeutics, neurodiagnostics, neurosurgery, and brain...

Logo
Vincy Ip
63 Views
Share
bullishMedtronic Plc
23 Nov 2023 01:14

Medtronic (MDT US): Beat-And-Raise Q2; Weight Loss Drugs Not to Impact Growth; New Device Approval

​Medtronic reported Q2FY24 organic revenue growth of 5%. The company raised FY24 organic revenue growth and EPS guidance. FDA approval for a new...

Logo
376 Views
Share
bullishMedtronic Plc
29 Feb 2024 13:04

Medtronic plc: Data Driven Innovations & 5 Major Drivers Of Its Future Growth! - Financial Forecasts

Medtronic delivered a solid quarter with its mid-single-digit revenue growth exceeding expectations. The fiscal '24 third quarter earnings were...

Logo
161 Views
Share
bullishMedtronic Plc
01 Jan 2024 08:03

Medtronic PLC: Can The New FDA Approval Help Them Revolutionize Hypertension Treatment? - Major Drivers

Medtronic plc delivered an all-around beat in the previous quarter, delivering mid-single-digit revenue growth across diverse business segments...

Logo
32 Views
Share
x